Spots Global Cancer Trial Database for chemoresistance
Every month we try and update this database with for chemoresistance cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
SMOLY : Phenotype and Functions of Monocyte Subtypes in High Grade B Lymphoma: Towards New Biomarkers? | NCT03672682 | DLBCL | 18 Years - 70 Years | Rennes University Hospital | ||
Macrophages Effect on Chemoresistance | NCT01921699 | the Focus of th... | taking blood sa... | 18 Years - 40 Years | Rambam Health Care Campus | |
Molecular Mechanisms Leading to Chemoresistance in Epithelial Ovarian Cancer | NCT02758652 | Ovarian Cancer | 18 Years - | Tampere University Hospital | ||
Role of the ATP7A Transporter in Ovarian Cancer | NCT05490407 | Gynecologic Can... Ovarian Cancer High Grade Sero... Chemotherapy Ef... | Carboplatin | 18 Years - 80 Years | University Medical Centre Ljubljana | |
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076) | NCT05281471 | Platinum-resist... Platinum-refrac... Fallopian Tube ... Primary Periton... High-grade Sero... Endometrioid Ov... Ovarian Clear C... | olvimulogene na... Platinum chemot... Non-platinum ch... Bevacizumab (or... | 18 Years - | Genelux Corporation | |
9-ING-41 in Patients With Advanced Cancers | NCT03678883 | Cancer Pancreatic Canc... Sarcoma Renal Cancer Refractory Canc... Refractory Neop... Refractory Non-... Pancreatic Aden... Resistant Cance... Neoplasm Metast... Neoplasm of Bon... Neoplasm, Breas... Neoplasm of Lun... Neoplasms,Color... Neoplasms Pancr... Malignant Gliom... Malignancies Malignancies Mu... Bone Metastases Bone Neoplasm Bone Cancer Pancreas Cancer Pancreatic Neop... Breast Neoplasm... Acute T Cell Le... | 9-ING-41 Gemcitabine - 2... Doxorubicin. Lomustine Carboplatin. Nab paclitaxel. Paclitaxel. Gemcitabine - 2... Irinotecan | 18 Years - | Actuate Therapeutics Inc. | |
Prediction of the Response to Chemotherapy by Tomoscintigraphie the MIBI in the Balance Sheet Pre Hodgkin's Disease and Lymphoma Malins High Grade | NCT00551798 | Hodgkin's Disea... Malignant Lymph... Chemoresistance | TEP au MIBI | 18 Years - | University Hospital, Limoges |